Charles Schwab Investment Management Inc Veracyte, Inc. Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Veracyte, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 735,007 shares of VCYT stock, worth $32.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
735,007
Previous 762,097
3.55%
Holding current value
$32.2 Million
Previous $16.5 Million
51.46%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding VCYT
# of Institutions
317Shares Held
81.1MCall Options Held
134KPut Options Held
13.3K-
Black Rock Inc. New York, NY7.79MShares$341 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.75MShares$339 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.02MShares$220 Million0.27% of portfolio
-
Wellington Management Group LLP Boston, MA4.23MShares$185 Million0.03% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.2MShares$184 Million1.46% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $3.13B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...